Thielbacked

Peter Thiel-backed psychedelic startup Atai Life Sciences, stocks rose on its first day of trading on Wall Street on Friday.The newly listed Nasdaq stock opened 40% before falling a little. The shares closed nearly 30% to $ 19.45 each.The…

LONDON - ATAI Life Science, a Peter Thiel-backed start-up, has acquired a majority stake in Recognify, a company that develops drugs to treat schizophrenia.ATAI is headquartered in Berlin and aims to manufacture psychedelics that can be…